Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

VYNE Therapeutics (VYNE) Debt Ratio (2019 - 2021)

VYNE Therapeutics (VYNE) has disclosed Debt Ratio for 3 consecutive years, with 0.25 as the latest value for Q2 2021.

  • For the quarter ending Q2 2021, Debt Ratio fell 0.98% year-over-year to 0.25, compared with a TTM value of 0.25 through Jun 2021, down 0.98%, and an annual FY2020 reading of 0.35, down 12.24% over the prior year.
  • Debt Ratio was 0.25 for Q2 2021 at VYNE Therapeutics, up from 0.22 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.4 in Q4 2019 and bottomed at 0.22 in Q1 2021.
  • Average Debt Ratio over 3 years is 0.3, with a median of 0.31 recorded in 2020.
  • Peak annual rise in Debt Ratio hit 0.98% in 2021, while the deepest fall reached 31.73% in 2021.
  • Year by year, Debt Ratio stood at 0.4 in 2019, then dropped by 12.24% to 0.35 in 2020, then dropped by 29.61% to 0.25 in 2021.
  • Business Quant data shows Debt Ratio for VYNE at 0.25 in Q2 2021, 0.22 in Q1 2021, and 0.35 in Q4 2020.